XENOGEN CORP
S-1/A, EX-27.1, 2000-12-29
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: XENOGEN CORP, S-1/A, EX-23.1, 2000-12-29
Next: ORASURE TECHNOLOGIES INC, S-4 POS, 2000-12-29



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   12-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999             SEP-30-2000
<PERIOD-START>                             JAN-01-1999             JAN-01-2000
<PERIOD-END>                               DEC-31-1999             SEP-30-2000
<CASH>                                           3,752                  18,819
<SECURITIES>                                     2,060                   9,281
<RECEIVABLES>                                      712                     339
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                     372
<CURRENT-ASSETS>                                 6,884                  30,146
<PP&E>                                           2,150                   3,164
<DEPRECIATION>                                   (979)                 (1,852)
<TOTAL-ASSETS>                                  11,613                  35,937
<CURRENT-LIABILITIES>                            1,916                   4,359
<BONDS>                                              0                       0
                           17,511                  46,502
                                          0                       0
<COMMON>                                             4                       5
<OTHER-SE>                                    (10,496)                (18,903)
<TOTAL-LIABILITY-AND-EQUITY>                    11,613                  35,937
<SALES>                                          1,293                   1,896
<TOTAL-REVENUES>                                 1,293                   1,896
<CGS>                                                0                     261
<TOTAL-COSTS>                                    8,547                  11,525
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                               (237)                   (375)
<INCOME-PRETAX>                                (7,136)                 (9,087)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                            (7,136)                 (9,087)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                   (7,136)                 (9,087)
<EPS-BASIC>                                    $(2.15)                 $(2.32)
<EPS-DILUTED>                                  $(2.15)                 $(2.32)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission